Obstetric Medicine

· 3 papers in corpus
2025
Efficacy and safety of casirivimab/imdevimab (REGEN-COV) in pregnant individuals with COVID-19: Literature review and insights from the COVID-19 International Drug Pregnancy Registry.
doi:10.1177/1753495x251343113 ·PMID:40503495

IntroductionCasirivimab/imdevimab (CAS/IMD) comprises two monoclonal antibodies that neutralize SARS-CoV-2. Pregnant individuals were excluded from initial trials, limiting safety data.MethodsThe COVID-19 International Drug Pregnancy Regist…

2023
ISOM/NASOM 2022 Abstracts
2016
Pregnancy outcomes of antiphospholipid syndrome: In a low resource South Asian setting.
doi:10.1177/1753495x16629300 ·PMID:27512499

ProblemAntiphospholipid syndrome is associated with recurrent pregnancy loss, and specific treatment improves pregnancy outcome. Laboratory diagnosis is limited in South Asia. We assessed management outcomes of definite/probable antiphospho…